Publications in collaboration with researchers from Hospital Ramón y Cajal (1)

2024

  1. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM)

    Life Sciences, Vol. 336